IDH1 and glioblastoma: According to the TCGA dataset, an increased risk score was highly related to the malignant progression of glioma, including IDH-WT status, 1p/19q non-codeletion, older age, higher WHO grade, more inclined to form glioblastoma, and worse response to treatment (Table 2; Figure 7A).